The jury is out on the culprit(s) behind the recent outbreak of vaping related lung injury. In this special report, Project CBD’s Chief Science writer, Adrian Devitt-Lee, suggests that synthetic cannabinoids could be partially responsible.
The use of cannabis as medicine for animals has been getting a lot attention in the medical, scientific, and pet owning communities. One of the potential uses showing the most promise is in the treatment of seizures. Does it work as well for pets as it does for people?
VAPING-RELATED LUNG INJURIES
Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Referred to as a “selective CB2 agonist,” such a compound would appear to have potential as a treatment for scleroderma.
Cannabinoids seem promising for treating the symptoms or progression of rheumatoid arthritis. A new controlled trial seeks to study CBD and THC’s impacat on arthritic pain.